IP
VRTX icon

Ignite Planners’s Vertex Pharmaceuticals VRTX Stock Holding History

Ignite Planners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$327K Buy
732
+65
+10% +$30.3K 0.05% 308
2025
Q4 		$313K Buy
+667
New +$287K 0.05% 320
2025
Q3 		– Sell
-462
Closed -$212K – 385
2025
Q2 		$212K Sell
462
-145
-24% -$66.8K 0.04% 340
2025
Q1 		$303K Buy
+607
New +$283K 0.06% 267

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ignite Planners's VRTX Position: Q1 2026 in Review

Ignite Planners increased its Vertex Pharmaceuticals (VRTX) stake by 9.7% in Q1 2026, buying an estimated $30.3K and bringing the position to 732 shares worth $327K. The position accounts for 0.05% of the portfolio, ranked #308.

Ignite Planners first reported a position in VRTX in Q1 2025 and has held it in 4 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Ignite Planners held 732 shares of Vertex Pharmaceuticals worth $327K as of Q1 2026.
  • Ignite Planners bought 65 Vertex Pharmaceuticals shares in Q1 2026, an estimated $30.3K.
  • Vertex Pharmaceuticals made up 0.05% of Ignite Planners's portfolio in Q1 2026, its #308 holding.
  • Ignite Planners first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Ignite Planners's 13F filing for Q1 2026, filed 17 Apr 2026.